Transaction · 0001628280-26-058684

Hayden Michael R

Hayden Michael R, DIR, reported an open-market or private purchase at AbCellera Biologics Inc. involving 53613.000000 shares for an estimated $570442.32. Reported holdings after the transaction were 1373397.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
ABCLAbCellera Biologics Inc.
Filing timeAug 24
Trade dateAug 24, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$10.61
Pre-filing
1mo ago -50.0%1w ago +5.6%1d ago +6.7%
Returns since
7d +15.3%30d +15.3%90d +15.3%180d +15.3%1y +15.3%

ABCL price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ABCL since 2026-08-24Filed 10 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001628280-26-058684
Common Shares
Transaction date
Aug 24, 2026
Filed Aug 24, 2026, 09:21 PM · 0d delay
Shares
53.6k sh
$1.06k per share
Estimated value
$57.0M
Computed from shares × price
Holdings after
1.37M sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Buy Director Buy
+36score
Filing-only score

+36

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.49 to $10.70. The reporting person undertakes to provide the…

  2. F2

    These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting per…

Original filing · 0001628280-26-058684
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ABCL